TCTMD

Your source for breaking news, topical videos, and slides covering cardiovascular disease and interventions. Register at

[TCTMD @TCTMD]

Did you guess correctly? This week's episode features Nicolas Van Mieghem! Listen to the full episode for more on his guiding mantra in life, his effort to maintain a balance between ambition and family, and more: https://t.co/ZcVQgXbJOs

@drnvanmieghem @TCTMD_Yael

[TCTMD @TCTMD]

Good Outcomes Maintained at 2 Years With Sapien M3 TMVR: ENCIRCLE https://t.co/Y8Oiu87YLw

[TCTMD @TCTMD]

The conversations from #TCT2026 keep coming. Mamas Mamas speaks with Rebecca Hahn about Australian data on severe tricuspid regurgitation and what it means for treatment decisions. Catch the full conversation behind the data, and stay tuned as our coverage continues: https://t.co/01YSRasYsw

[TCTMD @TCTMD]

How much autonomy should AI be given? Tony Das and Aasif Qasim discuss the possibilities and areas of concern that were highlighted during a #TCT2026 session.

[TCTMD @TCTMD]

During Elective PCI, High- and Low-Dose Heparin Provide Similar Outcomes https://t.co/99tH75YJcx

[TCTMD @TCTMD]

The FDA has approved asundexian for secondary stroke prevention, bringing a new class of oral anticoagulant to the market. High cost may be an initial barrier to uptake. Read TCTMD’s full coverage here: https://t.co/qZI7Telqo0

[TCTMD @TCTMD]

#TCT2026 coverage continues! @mirvatalasnag shares insight from a session discussing how to overcome barriers to MedTech on the global scale and reveals how inclusivity is essential to improving access. For all the latest news from TCT, click here: https://t.co/axx2rsxebs

[TCTMD @TCTMD]

ANGPTL4-Targeting Drug for High Triglycerides Moves Ahead: TYDAL-TIMI 78 https://t.co/8VXfzJTWxT

[TCTMD @TCTMD]

We're back with another guessing game! This month's guest joined us for a conversation at #TCT2026. Who do you think @TCTMD_Yael spoke to this time? Stay tuned to listen AND watch this episode on Wednesday to find out.

[TCTMD @TCTMD]

Better Outcomes With LBB vs RV Pacing for Atrioventricular Block https://t.co/2H5gvtFJOm

[TCTMD @TCTMD]

Early Signs of Vascular, Cardiorespiratory Problems Seen in Regular Vape Users https://t.co/lVMQDH2fvF

[TCTMD @TCTMD]

On-Duty Firefighter Deaths Are Increasingly Cardiac in Nature
https://t.co/3wMpBih3oh

[TCTMD @TCTMD]

Degenerative Mitral Valve Disease Rising Steadily Worldwide With Sharp Sex, Socioeconomic Divides https://t.co/65S8EbyXwv

[TCTMD @TCTMD]

@ColletCarlos and @esbrilakis share findings from the P4 trial presented at #TCT2026! For more details, read the full story on TCTMD: https://t.co/ENnP2pxp6W

[TCTMD @TCTMD]

SPYRAL-AFFIRM: Renal Denervation Safe, Effective in Patients Who Are Often Overlooked https://t.co/doblQ6ojIS

[TCTMD @TCTMD]

Tricuspid Repair Benefits Consistent Across TRIC-I-HF Subgroups https://t.co/YqdWbQhn96

[TCTMD @TCTMD]

SIMPLAAFY Supports Antithrombotic Monotherapy After LAAO https://t.co/jamTenTHwX

[TCTMD @TCTMD]

As TR Increases in Severity, It Also Becomes More Deadly https://t.co/uK7A53VsTe

[TCTMD @TCTMD]

PROGRESS: TAVI Is Effective, Safe in Moderate AS With At-Risk Features https://t.co/5nlIxVCmBC

[TCTMD @TCTMD]

Coronary Sinus Reducer Has Little Impact on ANOCA in Sham-Controlled Trial https://t.co/PPJ8gxgbZ3